Featured Research

from universities, journals, and other organizations

Baker’s yeast substance can aid healing, Norwegian researchers show

Date:
September 7, 2011
Source:
The Research Council of Norway
Summary:
Can wounds be helped to heal faster? Yes, says a Norwegian company whose product’s active ingredient, beta-glucans, comes from common baker’s yeast. Beta-glucans have been called nature's super-medicine. Norwegian researchers have been pioneers in producing these substances from the cell walls of everyday baker's yeast. Beta-glucans are now widely used in the aquaculture industry and veterinary medicine, as well as in dietary supplements and cosmetics.

Can wounds be helped to heal faster? Yes, says a Norwegian company whose product's active ingredient, beta-glucans, comes from common baker's yeast.

Beta-glucans have been called nature's super-medicine. Norwegian researchers have been pioneers in producing these substances from the cell walls of everyday baker's yeast. Beta-glucans are now widely used in the aquaculture industry and veterinary medicine, as well as in dietary supplements and cosmetics.

The true potential of beta-glucans has barely been touched upon, asserts Rolf Einar Engstad, Chief Scientific Officer at the Tromsψ-based company Biotec Pharmacon. He headed a project which over the past several years has enhanced the understanding of how beta-glucans work and how they can be applied.

Promising medicinal effects on humans

"Since the mid-1980s we have known that these substances fight infection and have a bearing on the body's ability to kill cancerous cells," explains Dr Engstad, "but we never knew why. With funding from the Programme for User-driven Research-based Innovation (BIA) under the Research Council of Norway, we have carried out a project that gives us insight into the working mechanisms of beta-glucans." Biotec Pharmacon received assistance from Rikshospitalet University Hospital in Oslo during the project.

"When we started the project we didn't know whether the substance needed to be taken up in the blood or if its effect was local," recalls Anders Sandvik, who earned his PhD in beta-glucans.

"To find out, we conducted experiments on rats, introducing bacterial components into the blood to see what would happen. We determined that animals receiving beta-glucan orally acquired protection that was at least as good as rats that received an injection into their bloodstream."

This was a promising development for the Tromsψ company, which had already found that its product, a beta-glucan gel, was effective in helping wounds to heal quickly.

Storage a challenge

"Some time into the project," adds Dr Engstad, "we experienced problems maintaining product strength and efficacy. It turned out the gel became unstable after a year in storage. So we added in a new substance during the study that restored the gel's healing effect."

Now that the project has concluded, Biotec Pharmacon is working on a beta-glucan formula that remains stable during storage.

On the market in 2012

"We're also examining the possibility of developing the healing gel under the statutory framework for medical devices rather than as a medicine," says Dr Engstad. "The requirements for clinical documentation of the product are less stringent, and we could get it to market far sooner."

"I believe that in the course of 2012 we will be ready to launch it."

"This will be a unique product that can be used for treating all types of wounds: surgical incisions, diabetic ulcers and bedsores," says Dr Engstad. "There is nothing on the global market that heals wounds in the same way."

Asthma and allergy treatments next

Biotec Pharmacon does not plan to stop at wound healing. The firm eyes even greater potential for beta-glucan ahead.

"Over the past few years, we've come to understand that beta-glucan has an effect on our innate immune system, which is the first line of defence in people and in practically every animal. It takes care of 99 per cent of all invasions we are exposed to, and it engages before the human body's adaptive immune system manages to react."

Many disorders are related to this innate immune system, such as allergies, asthma, chronic fatigue syndromes and cancer.

Biotec Pharmacon has been cooperating with Memorial Sloan-Kettering Cancer Center in New York for many years. The Americans have done studies using the beta-glucan from Tromsψ on US cancer patients and found that it contributes to the healing effect of antibodies introduced to patients.

Funding has made the difference

"The several years of funding under the BIA programme has put Biotec Pharmacon in a position to carry out basic research and product development at the same time and has helped the company through a critical phase to where it is now," says Dr Engstad. He also feels that winning funding from the Research Council of Norway is a stamp of quality.

"It takes a lot of money to carry out studies of potential medicines like ours. Now we've submitted a patent application for an exciting finding we've made in connection with preventing asthma, but at the moment we don't have the financial muscle to take its development to the next level."


Story Source:

The above story is based on materials provided by The Research Council of Norway. The original article was written by Siw Ellen Jakobsen/Else Lie; translation by Darren McKellep/Carol B. Eckmann. Note: Materials may be edited for content and length.


Cite This Page:

The Research Council of Norway. "Baker’s yeast substance can aid healing, Norwegian researchers show." ScienceDaily. ScienceDaily, 7 September 2011. <www.sciencedaily.com/releases/2011/09/110907085356.htm>.
The Research Council of Norway. (2011, September 7). Baker’s yeast substance can aid healing, Norwegian researchers show. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2011/09/110907085356.htm
The Research Council of Norway. "Baker’s yeast substance can aid healing, Norwegian researchers show." ScienceDaily. www.sciencedaily.com/releases/2011/09/110907085356.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) — The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins